The impact of COVID-19 infection, the pandemic and its associated control measures on patients with Pompe disease.

ABSTRACT:

Background

Patients with Pompe disease, a rare metabolic myopathy, were thought to be at increased risk of severe COVID-19 disease during the pandemic. In addition, the lockdown may have affected their regular treatment.

Objective

To assess the perceived effect of COVID-19 infection and of the pandemic on the treatment, and physical and mental health of patients with Pompe disease.

Methods

Patients with Pompe disease over 16 years of age participated in an international, cross-sectional, online survey (September 20, 2022-November 7, 2022). The questionnaire, available in eight languages, consisted of 89 questions divided into 3 parts: (A) severity of Pompe disease, (B) COVID-19 precautions and infection(s) and (C) effects of the COVID-19 pandemic.

Results

Among

SUBMITTER: Theunissen MTM 

PROVIDER: S-EPMC10769914 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature